Symbols / NBY $1.41 -2.76%
NBY Chart
About
NovaBay Pharmaceuticals, Inc. manufactures and sells wound care products. The company offers hypochlorous acid for use in the cleansing and irrigation of post-surgical wounds, minor burns, and superficial abrasions. It sells its products to its distribution partners in China. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 36.84M |
| Enterprise Value | 39.52M | Income | -6.99M | Sales | 10.30M |
| Book/sh | -2.23 | Cash/sh | 0.09 | Dividend Yield | — |
| Payout | 0.00% | Employees | 13 | IPO | — |
| P/E | 0.05 | Forward P/E | -1.72 | PEG | — |
| P/S | 3.58 | P/B | -0.63 | P/C | — |
| EV/EBITDA | -7.75 | EV/Sales | 3.84 | Quick Ratio | 1.89 |
| Current Ratio | 2.00 | Debt/Eq | 59.36 | LT Debt/Eq | — |
| EPS (ttm) | 25.80 | EPS next Y | -0.82 | EPS Growth | — |
| Revenue Growth | -78.70% | Earnings | 2025-08-12 15:00 | ROA | -86.98% |
| ROE | -5.16% | ROIC | — | Gross Margin | 63.32% |
| Oper. Margin | -224.38% | Profit Margin | 31.48% | Shs Outstand | 26.12M |
| Shs Float | 2.05M | Short Float | 27.23% | Short Ratio | 1.87 |
| Short Interest | — | 52W High | 99.75 | 52W Low | 1.11 |
| Beta | 0.20 | Avg Volume | 612.63K | Volume | 358.70K |
| Target Price | — | Recom | None | Prev Close | $1.45 |
| Price | $1.41 | Change | -2.76% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$1.36
Latest analyst target
3. DCF / Fair value
$-1.82
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.36
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-11-11 | main | Ascendiant Capital | Buy → Buy | $1 |
| 2023-08-11 | main | Ladenburg Thalmann | Buy → Buy | $4 |
News
RSS: Latest NBY news- NBY Stock Price, Quote & Chart | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - ChartMill Fri, 13 Mar 2026 07
- NBY SEC Filings - Novabay Pharma 10-K, 10-Q, 8-K Forms - Stock Titan Sat, 28 Feb 2026 16
- Assessing NovaBay Pharmaceuticals’ (NBY) Valuation After A Sharp Short Term Share Price Surge - Yahoo Finance Sun, 11 Jan 2026 08
- NovaBay Pharmaceuticals shareholders approve charter amendments and stock issuance By Investing.com - Investing.com Nigeria Mon, 16 Mar 2026 00
- NovaBay falls on deal for $100M stock (update) (NBY:NYSE) - Seeking Alpha ue, 20 Jan 2026 08
- NovaBay Pharma Expands Share Capital and Governance Flexibility - TipRanks hu, 12 Mar 2026 21
- NovaBay enters into $6M securities purchase agreement with investor David Lazar - MSN Sun, 08 Mar 2026 09
- NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Up 14.2% - Should You Buy? - MarketBeat Mon, 05 Jan 2026 08
- NBY Stock Up 100%: What Just Happened to NovaBay Stock? - EBC Financial Group Mon, 12 Jan 2026 08
- 12 Health Care Stocks Moving In Wednesday's After-Market Session - Sahm Wed, 11 Mar 2026 06
- Why NovaBay Pharmaceuticals (NBY) Is Up 99.3% After Pivoting From Liquidation To Restructuring And Asset Sales - simplywall.st ue, 13 Jan 2026 08
- NBY Stock Jumps Amid Market Anticipation and Economic Data Uncertainty - StocksToTrade Sun, 21 Dec 2025 08
- NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar - TechStock² Mon, 12 Jan 2026 08
- Poplar Point cuts NovaBay (NBY) ownership below 5% reporting level - Stock Titan Wed, 11 Mar 2026 17
- NovaBay Pharmaceuticals stock falls after $100 million ATM offering - Investing.com ue, 20 Jan 2026 08
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 6388000 | — | — | LAZAR DAVID ELLIOT | Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-21 00:00:00 | D | nan |
| 1 | 6388000 | — | Conversion of Exercise of derivative security at price 99.08 per share. | LAZAR DAVID ELLIOT | Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-21 00:00:00 | D | 632923040.0 |
| 2 | 56806080 | — | — | R01 FUND L.P. | Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-21 00:00:00 | I | nan |
| 3 | 56806080 | — | — | KAZLEY MICHAEL JOHN | Chief Executive Officer | — | 2025-10-21 00:00:00 | I | nan |
| 4 | 56806080 | — | — | FRAMEWORK VENTURES IV L.P. | Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-21 00:00:00 | I | nan |
| 5 | 28731 | — | Purchase at price 0.46 - 0.58 per share. | POPLAR POINT CAPITAL PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | — | 2025-04-08 00:00:00 | D | 15967.0 |
| 6 | 123365 | — | Purchase at price 0.58 - 0.62 per share. | POPLAR POINT CAPITAL PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | — | 2025-04-01 00:00:00 | I | 74519.0 |
| 7 | 49927 | — | Purchase at price 0.60 - 0.63 per share. | POPLAR POINT CAPITAL PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | — | 2025-03-25 00:00:00 | I | 30718.0 |
| 8 | 64175 | — | Purchase at price 0.58 - 0.64 per share. | POPLAR POINT CAPITAL PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | — | 2025-03-18 00:00:00 | I | 39503.0 |
| 9 | 48930 | — | Purchase at price 0.55 - 0.62 per share. | POPLAR POINT CAPITAL PARTNERS L P | Beneficial Owner of more than 10% of a Class of Security | — | 2025-03-07 00:00:00 | I | 29858.0 |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -5.14M | -4.41M | -4.54M | -13.36M |
| TotalUnusualItems | -782.00K | 312.00K | -2.65M | 4.62M |
| TotalUnusualItemsExcludingGoodwill | -782.00K | 312.00K | -2.65M | 4.62M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -7.21M | -6.14M | -10.61M | -5.82M |
| ReconciledDepreciation | 381.00K | 356.00K | 483.00K | 119.00K |
| ReconciledCostOfRevenue | 3.30M | 4.37M | 6.62M | 3.69M |
| EBITDA | -5.92M | -4.09M | -7.20M | -8.74M |
| EBIT | -6.31M | -4.45M | -7.68M | -8.86M |
| NetInterestIncome | -904.00K | -1.69M | ||
| InterestExpense | 904.00K | 1.69M | ||
| NormalizedIncome | -6.43M | -6.46M | -7.96M | -10.44M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -7.22M | -9.64M | -10.61M | -5.82M |
| TotalExpenses | 14.76M | 14.56M | 22.08M | 19.07M |
| TotalOperatingIncomeAsReported | -5.84M | -4.10M | -14.42M | -8.86M |
| DilutedAverageShares | 679.20K | 24.00K | 9.20K | 7.12K |
| BasicAverageShares | 679.20K | 24.00K | 9.20K | 7.12K |
| DilutedEPS | -12.65 | -695.70 | -1.77K | -920.50 |
| BasicEPS | -12.65 | -695.70 | -1.77K | -920.50 |
| DilutedNIAvailtoComStockholders | -8.61M | -16.70M | -16.27M | -6.56M |
| NetIncomeCommonStockholders | -8.61M | -16.70M | -16.27M | -6.56M |
| OtherunderPreferredStockDividend | 1.39M | 7.06M | 5.66M | 0.00 |
| PreferredStockDividends | 735.00K | |||
| NetIncome | -7.22M | -9.64M | -10.61M | -5.82M |
| NetIncomeIncludingNoncontrollingInterests | -7.22M | -9.64M | -10.61M | -5.82M |
| NetIncomeDiscontinuousOperations | -13.00K | -3.50M | ||
| NetIncomeContinuousOperations | -7.21M | -6.14M | -10.61M | -5.82M |
| TaxProvision | 0.00 | |||
| PretaxIncome | -7.21M | -6.14M | -10.61M | -5.82M |
| OtherIncomeExpense | -1.33M | -349.00K | -2.93M | 3.04M |
| OtherNonOperatingIncomeExpenses | -550.00K | -661.00K | -276.00K | -1.58M |
| SpecialIncomeCharges | -878.00K | 0.00 | -6.18M | 0.00 |
| GainOnSaleOfBusiness | -865.00K | 0.00 | ||
| OtherSpecialCharges | 13.00K | |||
| ImpairmentOfCapitalAssets | 2.59M | 6.74M | 0.00 | |
| RestructuringAndMergernAcquisition | 0.00 | -561.00K | 0.00 | |
| GainOnSaleOfSecurity | 96.00K | 312.00K | 3.52M | 4.62M |
| NetNonOperatingInterestIncomeExpense | -904.00K | -1.69M | ||
| InterestExpenseNonOperating | 904.00K | 1.69M | ||
| OperatingIncome | -4.97M | -4.10M | -7.68M | -8.86M |
| OperatingExpense | 11.46M | 10.19M | 15.46M | 15.38M |
| ResearchAndDevelopment | 42.00K | 34.00K | 174.00K | 44.00K |
| SellingGeneralAndAdministration | 11.41M | 10.15M | 15.29M | 15.33M |
| SellingAndMarketingExpense | 4.03M | 4.71M | 7.80M | 8.09M |
| GeneralAndAdministrativeExpense | 7.38M | 5.45M | 7.49M | 7.24M |
| OtherGandA | 7.38M | 5.45M | 7.49M | 7.24M |
| GrossProfit | 6.48M | 6.08M | 7.78M | 6.51M |
| CostOfRevenue | 3.30M | 4.37M | 6.62M | 3.69M |
| TotalRevenue | 9.78M | 10.46M | 14.40M | 10.20M |
| OperatingRevenue | 9.75M | 10.46M | 14.37M | 10.18M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 977.14K | 64.17K | 11.63K | 7.80K |
| ShareIssued | 977.14K | 64.17K | 11.63K | 7.80K |
| NetDebt | 135.00K | |||
| TotalDebt | 1.67M | 2.61M | 2.04M | 551.00K |
| TangibleBookValue | -135.00K | 1.36M | 4.95M | -237.00K |
| InvestedCapital | 430.00K | 2.50M | 7.58M | 9.60M |
| WorkingCapital | -908.00K | 2.88M | 7.08M | 9.73M |
| NetTangibleAssets | -129.00K | 3.31M | 7.93M | 443.00K |
| CapitalLeaseObligations | 1.11M | 1.48M | 2.04M | 446.00K |
| CommonStockEquity | -135.00K | 1.36M | 7.58M | 9.49M |
| PreferredStockEquity | 6.00K | 1.95M | 2.97M | 680.00K |
| TotalCapitalization | -129.00K | 3.31M | 10.55M | 10.17M |
| TotalEquityGrossMinorityInterest | -129.00K | 3.31M | 10.55M | 10.17M |
| StockholdersEquity | -129.00K | 3.31M | 10.55M | 10.17M |
| RetainedEarnings | -183.46M | -174.85M | -158.15M | -141.89M |
| AdditionalPaidInCapital | 183.27M | 176.21M | 165.71M | 150.90M |
| CapitalStock | 55.00K | 1.95M | 2.99M | 1.16M |
| CommonStock | 49.00K | 3.00K | 20.00K | 478.00K |
| PreferredStock | 6.00K | 1.95M | 2.97M | 680.00K |
| TotalLiabilitiesNetMinorityInterest | 3.55M | 5.72M | 5.84M | 13.81M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 709.00K | 1.44M | 1.59M | 10.37M |
| OtherNonCurrentLiabilities | 334.00K | 561.00K | ||
| DerivativeProductLiabilities | 0.00 | 334.00K | 0.00 | 9.56M |
| LongTermDebtAndCapitalLeaseObligation | 709.00K | 1.11M | 1.59M | 246.00K |
| LongTermCapitalLeaseObligation | 709.00K | 1.11M | 1.59M | 246.00K |
| CurrentLiabilities | 2.84M | 4.28M | 4.26M | 3.44M |
| OtherCurrentLiabilities | 698.00K | |||
| CurrentDeferredLiabilities | 488.00K | 946.00K | 1.81M | 1.29M |
| CurrentDeferredRevenue | 488.00K | 946.00K | 1.81M | 1.29M |
| CurrentDebtAndCapitalLeaseObligation | 963.00K | 1.50M | 453.00K | 305.00K |
| CurrentCapitalLeaseObligation | 398.00K | 368.00K | 453.00K | 200.00K |
| CurrentDebt | 565.00K | 1.14M | 105.00K | |
| OtherCurrentBorrowings | 565.00K | 1.14M | ||
| LineOfCredit | 0.00 | 105.00K | ||
| PayablesAndAccruedExpenses | 1.39M | 1.13M | 2.00M | 1.85M |
| CurrentAccruedExpenses | 769.00K | 223.00K | 917.00K | 803.00K |
| Payables | 623.00K | 906.00K | 1.08M | 1.04M |
| AccountsPayable | 623.00K | 906.00K | 1.08M | 1.04M |
| TotalAssets | 3.42M | 9.03M | 16.40M | 23.98M |
| TotalNonCurrentAssets | 1.49M | 1.88M | 5.07M | 10.81M |
| OtherNonCurrentAssets | 480.00K | 497.00K | 489.00K | 476.00K |
| GoodwillAndOtherIntangibleAssets | 0.00 | 2.63M | 9.73M | |
| OtherIntangibleAssets | 2.28M | 5.20M | ||
| Goodwill | 0.00 | 348.00K | 4.53M | |
| NetPPE | 1.01M | 1.38M | 1.95M | 604.00K |
| AccumulatedDepreciation | -689.00K | -673.00K | -622.00K | -641.00K |
| GrossPPE | 1.70M | 2.06M | 2.57M | 1.25M |
| Leases | 152.00K | 152.00K | 152.00K | 79.00K |
| OtherProperties | 1.83M | 114.00K | ||
| MachineryFurnitureEquipment | 590.00K | 608.00K | 589.00K | 641.00K |
| BuildingsAndImprovements | 955.00K | 1.30M | 1.83M | 411.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 1.94M | 7.15M | 11.33M | 13.17M |
| OtherCurrentAssets | 110.00K | 81.00K | 159.00K | 129.00K |
| AssetsHeldForSaleCurrent | 48.00K | 2.79M | ||
| PrepaidAssets | 117.00K | 90.00K | 358.00K | 631.00K |
| Inventory | 765.00K | 501.00K | 3.44M | 3.22M |
| InventoriesAdjustmentsAllowances | -106.00K | -264.00K | -499.00K | -641.00K |
| OtherInventories | -48.00K | -2.35M | ||
| FinishedGoods | 792.00K | 2.17M | 2.66M | 2.68M |
| RawMaterials | 127.00K | 943.00K | 1.27M | 1.18M |
| Receivables | 465.00K | 765.00K | 2.02M | 1.69M |
| OtherReceivables | 76.00K | 85.00K | 43.00K | 18.00K |
| AccountsReceivable | 389.00K | 680.00K | 1.97M | 1.67M |
| AllowanceForDoubtfulAccountsReceivable | -3.00K | -3.00K | -19.00K | 0.00 |
| GrossAccountsReceivable | 392.00K | 683.00K | 1.99M | 1.67M |
| CashCashEquivalentsAndShortTermInvestments | 430.00K | 2.92M | 5.36M | 7.50M |
| CashAndCashEquivalents | 430.00K | 2.92M | 5.36M | 7.50M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.19M | -4.28M | -6.77M | -9.24M |
| RepaymentOfDebt | -1.99M | -1.47M | -105.00K | 0.00 |
| IssuanceOfDebt | 500.00K | 3.00M | 0.00 | 105.00K |
| IssuanceOfCapitalStock | 2.86M | 0.00 | 3.04M | 16.68M |
| CapitalExpenditure | -6.00K | -19.00K | -112.00K | -52.00K |
| InterestPaidSupplementalData | 147.00K | 189.00K | 17.00K | 0.00 |
| IncomeTaxPaidSupplementalData | 359.00K | 24.00K | 21.00K | |
| EndCashPosition | 907.00K | 3.40M | 5.85M | 7.98M |
| OtherCashAdjustmentOutsideChangeinCash | 126.00K | 297.00K | ||
| BeginningCashPosition | 3.61M | 5.85M | 7.98M | 12.43M |
| ChangesInCash | -2.83M | -2.74M | -2.13M | -4.45M |
| CashFlowFromDiscontinuedOperation | -206.00K | -373.00K | ||
| FinancingCashFlow | 1.50M | 1.91M | 4.63M | 16.79M |
| CashFlowFromContinuingFinancingActivities | 1.50M | 1.91M | 4.63M | 16.79M |
| NetOtherFinancingCharges | -115.00K | -181.00K | ||
| ProceedsFromStockOptionExercised | 247.00K | 565.00K | 1.70M | 0.00 |
| NetPreferredStockIssuance | 0.00 | 3.04M | 14.91M | |
| PreferredStockIssuance | 0.00 | 3.04M | 14.91M | |
| NetCommonStockIssuance | 2.86M | 0.00 | 0.00 | 1.78M |
| CommonStockIssuance | 2.86M | 0.00 | 0.00 | 1.78M |
| NetIssuancePaymentsOfDebt | -1.49M | 1.53M | -105.00K | 105.00K |
| NetShortTermDebtIssuance | -1.49M | 1.53M | -105.00K | 105.00K |
| ShortTermDebtPayments | -1.99M | -1.47M | -105.00K | |
| ShortTermDebtIssuance | 500.00K | 3.00M | 0.00 | 105.00K |
| NetLongTermDebtIssuance | 0.00 | |||
| LongTermDebtPayments | 0.00 | |||
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | 1.06M | -19.00K | -112.00K | -12.04M |
| CashFlowFromContinuingInvestingActivities | 1.06M | -19.00K | -112.00K | -12.04M |
| NetBusinessPurchaseAndSale | 1.07M | 0.00 | 0.00 | -11.99M |
| SaleOfBusiness | 1.07M | 0.00 | ||
| PurchaseOfBusiness | 0.00 | -11.99M | ||
| NetPPEPurchaseAndSale | -6.00K | -19.00K | -112.00K | -52.00K |
| PurchaseOfPPE | -6.00K | -19.00K | -112.00K | -52.00K |
| OperatingCashFlow | -5.18M | -4.26M | -6.65M | -9.19M |
| CashFlowFromContinuingOperatingActivities | -5.18M | -4.26M | -6.65M | -9.19M |
| ChangeInWorkingCapital | -595.00K | -433.00K | 533.00K | -38.00K |
| ChangeInOtherCurrentLiabilities | -369.00K | -319.00K | 1.59M | -57.00K |
| ChangeInOtherCurrentAssets | -2.00K | -6.00K | -1.43M | 25.00K |
| ChangeInPayablesAndAccruedExpense | -195.00K | -1.13M | 667.00K | -163.00K |
| ChangeInPayable | -195.00K | -1.13M | 667.00K | -163.00K |
| ChangeInAccountPayable | -195.00K | -1.13M | 667.00K | -163.00K |
| ChangeInPrepaidAssets | -48.00K | 11.00K | 218.00K | -52.00K |
| ChangeInInventory | -272.00K | 162.00K | -217.00K | -243.00K |
| ChangeInReceivables | 291.00K | 846.00K | -305.00K | 452.00K |
| ChangesInAccountReceivables | 291.00K | 846.00K | -305.00K | 452.00K |
| OtherNonCashItems | 1.13M | 1.29M | -561.00K | |
| StockBasedCompensation | 148.00K | 291.00K | 220.00K | 1.15M |
| AssetImpairmentCharge | 2.60M | 6.80M | 0.00 | |
| DepreciationAmortizationDepletion | 381.00K | 356.00K | 483.00K | 119.00K |
| DepreciationAndAmortization | 381.00K | 356.00K | 483.00K | 119.00K |
| AmortizationCashFlow | 152.00K | 363.00K | 60.00K | |
| AmortizationOfIntangibles | 152.00K | 363.00K | 60.00K | |
| Depreciation | 381.00K | 356.00K | 120.00K | 59.00K |
| OperatingGainsLosses | 851.00K | -20.00K | -3.52M | -4.60M |
| GainLossOnInvestmentSecurities | -27.00K | -20.00K | -3.52M | -4.60M |
| GainLossOnSaleOfPPE | 0.00 | |||
| GainLossOnSaleOfBusiness | 865.00K | 0.00 | ||
| NetIncomeFromContinuingOperations | -7.10M | -5.74M | -10.61M | -5.82M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NBY
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|